Ischaemic heart disease as an effect of obesity-related metabolic disturbances

Central European Journal of Public Health

Volumn 7, Issue 3, 1999, Pages 122-129

  Indulski, J A ^a   Lutz, W ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Cholesterol; Fatty acids; Heart diseases; Hyperinsulinaemia; Metabolic disturbances; Obesity; Triacylglycerols

Indexed keywords

CHOLESTEROL; FAT; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; DIET; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; HEREDITY; HUMAN; HYPERINSULINEMIA; HYPERMETABOLISM; INDUSTRIAL AREA; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIVER METABOLISM; MALE; METABOLIC DISORDER; MORBIDITY; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; RISK FACTOR; URBAN AREA;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS; GLUCOSE; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; MYOCARDIAL ISCHEMIA; OBESITY; RISK FACTORS;

EID: 0032781846     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Van Itallie, T. B., Wotecki, C. E.: Who gets fat? In: Body Weight Control, Churchill Livingstone, New York, 1987, 39-52.
2. Bialłkowska, M.: Obesity, definition, identification methods. In: Obesity as Civilization Disease. Baranowska B., Białkowska M., Wasilewska-Dziubińska E., Pachocki R. (eds), Bell Corporation., Warszawa, 1994, 5-17 (In Polish.)
3. Cybulska, B., Szostak, W. B.: Visceral obesity as the risk factor of coronary heart disease. Pol. Tyg Lek. 50, suppl. 1, 1995, 43-47.
4. 2) as a measure of fatness. Int. J. Obes. 9, 1995, 147-153.
5. Panotopoulos, G., Ruiz, J. C., Raison, J., Guy-Grand, B., Basdevant, A.: Menopause, fat and lean distribution in obese women, Maturitas 25, 1996, 11-19.
6. Hopper, D., Barker, M. E.: Dietary advice, nutritional knowledge and attitudes towards nutrition in primary health care. J. Hum. Nutr. Diet 8, 1995, 279-286.
7. Willett, W. C.: Is dietary fat a major determinant of body fat? Amer. J. Clin. Nutr. 67. suppl. 1, 1998, 556-562.
8. Potter, J. D.: Food, nutrition and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research. Washington, 1997.
9. Saville, P. D., Dickson, J.: Age weight in osteoarthrosis of the hip. Arthritis Rheum. 11, 1968, 635-646.
10. Dietschy, J. M.: Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol. Amer. J. Clin. Nutr. 65, suppl. 1, 1997, 1581-1589.
11. Grundy, S. M.: Multifactorial causation of obesity: implications for prevention. Amer. J. Clin. Nutr. 67, suppl. 1, 563-572.
12. Newgard, C. B., McGarry, J, D.: Metabolic coupling factors in pancreatic β-cell signal transduction. Ann. Rev. Biochem. 64, 1995, 689-719.
13. Pearson, T. A., LaCava, J., Weil, H. F. C.: Epidemiology of thrombotic - hemosiatic factors and their associations with cardiovascular disease. Amer. J. Clin. Nutr. 65, suppl. 1, 1674-1682.
14. Sclafani, A.: Diet-induced obesity. In: Obesity: Theory and Therapy. Stunkard, A. J , Wadden, T A. (eds). Raven Press, Ltd , New York 1993, 125-135
15. Lonnquist, F., Arner, F., Nordfols, L., Schalling, M.: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med 1, 1994, 950-956.
16. Reaven, G. M.: Role of insulin resistance in human diseases Diabetes 37, 1988, 1595-1607.
17. Tatoń, J.: Obesity pathogenesis. Pol. Tyg. Lek. 50, suppl. 1, 1995, 3-10 (In Polish.)
18. Kelley, D. E., Mokan, M., Simonenau, J.-A., Mandarino, L. J.: Interaction between glucose and fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92, 1993, 91-98.
19. Rimon, D. L.: Genetic syndromes associated with glucose intolerance. In: The Genetics of Diabetes Mellitus. Springer-Verlag. Berlin 1976, 125-162.
20. Committee Report: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1997, 1183-1197.
21. Reaven, G. M.: The role of insulin resistance and hyperinsulinemia in coronary heart disease Metabolism 41, 992, 16-19.
22. Campbell, P. J., Carlson, M. G., Nurjhan, N.: Fat metabolism in human obesity Amer. J. Physiol 266, 1994, 600-605.
23. Grundy, S. M.: Atherogenic dyslipidemia and the metabolic syndrome. pathogenesis and challenge of therapy. In: Drugs affecting lipid metabolism. Gotto, A. M. (ed). Kluwer Academic Publishers. Dordrecht. Netherlands 1996, 237-247.
24. Blade, B., Vega, G. L., Grundy, S. M.: Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb 13, 1993, 1227-1235
25. Lonnquist, F., Thorne, A., Nilsen, K., Hoffstedt, J., Arner, P.: A pathogenic role of visceral β3 adrenoreceptors in obesity. J. Clin Invest 95, 1995, 1100-1116.
26. Horton, T. J., Drougas, H., Brachey, A., Reed, G. W., Peters, J. C., Hill, J. O.: Fat and carbohydrate overfeeding humans: different effects on energy storage Amer J. Clin. Nutr. 62, 1995, 19-29
27. Caggiula, A. W., Mustad, V. A.: Effects of dietary fat and fatty acids on coronary artery disease risk and total and lipoprotein cholesterol concentrations: epidemiologic studies. Amer. J. Clin. Nutr. 65, suppl. 1, 1997, 1597-1610.
28. Kris-Etherton, P. M., Dietschy, J.: Design criteria for studies examining individual fatty acid effect on cardiovascular disease risk factors, human and animal studies. Amer J. Clin. Nutr. 65, suppl. 1, 1997, 1590-1596.
29. Griffin, B. A., Zampelas, A.: Influence of dietary fatty acids on the atherogenic lipoprotein phenotype. Nutr. Res. Rev. 8, 1995, 1-26
30. Ascherio, A., Rimm, E: B., Stampfer, M. J., Giovannucci, E. L., Willen, W. C.: Dietary intake of marine n = 3 fatty acids, fish intake, and the risk of coronary heart disease among men. N Engl. J. Med. 332, 1995, 977-982
31. Judd, J., Clevidence, B., Muesing, R., Wittes, J., Sunkin, M., Pdczasy, J.; Dietary trans fatty acids; effect on plasma lipids and lipoproteins of healthy men and women Amer. J. Clin Nutr. 59, 1994, 861-868.
32. Seidel, J. C.: Dietary fat and obesity: an epidemiologic perspective. Amer. J Clin. Nutr. 67, suppl. 1, 1998, 546-550.
33. Brown, M. S., Goldstein, J. L.: A receptor-mediated pathway for cholesterol homeostasis. Science, 232, 1986, 34-47.
34. Fielding, C. J.: Response of LDL cholesterol to dietary change: contribution of different mechanisms Curr. Opi. Lipidol 8, 1997, 39-42
35. Wang, X., Sato, R., Brown, M. S., Hua, X., Goldstein, J. L.: SREBP-I a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell, 77, 1994, 53-62.
36. Willinow, T. E., Sheng, Z., Ishbashi, S., Herz, J.: Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science, 264, 1994, 1471-1474.
37. Dietschy, J. M., Turley, S. D., Spady, D. K.; Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34, 1993, 1637-1659.
38. Spady, D. K., Woollett, L. A., Dietschy, J. M.: Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Ann Rev Nutr 13, 1993, 355-381.
39. Wolfe, R. R.: Metabolic interaction between glucose and fatty acids in humans. Amer. J. Clin. Nutr. 67, suppl. 1, 1998, 519-526
40. Suckling, K. E., Stange, E. F.: Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism J. Lipid Res. 26, 1985, 647-671.
41. Daumerie, C. M., Woolett, L. A., Dietshy, J. M.: Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools Proc. Natl Acad. Sci USA, 89, 1992, 10797-10801.
42. Fielding, C. J., Fielding, P. E.: Molecular physiology of reverse cholesterol transport J Lipid Res. 36, 1995, 211-228.
43. Havel, P. J.: Functional activities of hepatic lipoprotein receptors Ann. Rev. Physiol 48, 1986, 119-134.
44. Johnson, W. J., Mahlberg, F. H., Rothblat, G. H., Philips, M. C.: Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta 1085, 1991, 273-298.
45. Kowal, R. C., Herz, J., Goldstein, N., Esser, V., Brown, M. S.: Low density lipoprotein receptor-related protein mediates uptake of cholesterol esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA, 86, 1989, 5810-5814.
46. Tall, A. R.: Plasma cholesterol ester transfer protein. J. Lipid Res 34, 1993, 1255-1274.
47. Mensink, R., Zock, P., Katan, M., Hornstra, G.: Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J. Lipid Res. 33, 1992, 1493-1501.
48. Siguel, E. N., Lerman, R. H.: Trans fatty acids patterns in patients with angiographically documented coronary artery disease Amer. J Cardiol. 71, 1993, 916-920.
49. Kris-Etherton, P. M.: Trans fatty acids and coronary heart disease risk. Amer J. Clin Nutr. 62, 1995, 655-708
50. Jonnalagadda, S. S., Mustad, V. A., Yu, S., Etherton, T. D., Kris-Etherton, P. M.: Effects of individual fatty acids on chronic diseases. Nutr Today 31, 1996, 90-106
51. Defronzo, R. A., Bonadonna, R. C., Ferrannini, E.: Pathogenesis of NIDDM. A balanced overview. Diabetes Care 42, 1993, 1567-1573.
52. McGarry, J. D.: Does leptin lighten the problem of obesity? Curr. Biol. 5, 1995, 1342-1344.
53. McGarry, J. D.: Glucose-fatty acid interactions in health and disease. Amer. J. Clin Nutr. 67, suppl. 1, 1998, 500-504.
54. Havel, P. J.: Leptin production and action: relevance to energy balance in humans. Amer. J Clin. Nutr 67, 1998, 355-356.
55. Blickman, R. M., Sabesin, S. M.: Lipoprotein metabolism. In. The Liver Biology and Pathobiology. Jakoby, W. B., Popper, H., Schachter, D., Shafritz, D. A. (eds). Raven Press, New York 1988, 331-354
56. Dixon, J. L., Ginsberg, H. N.: Regulation of hepatic secretion of apolipoprotein B-containing lipopoteins: information obtained from cultured liver cells J. Lipid Res. 34, 1993, 167-179.
57. Roust, L. R., Hammel, K. D., Jensen, M. D.: Effects of isoenergetic. low-fat diets on energy metabolism in lean and obese women. Amer J Clin. Nutr 60, 1994, 470-475
58. Sidossis, L., Wolfe, R. R.: Hyperglycemia-induced inhibition of fatty acid oxidation the glucose-fatty acid cycle reversed Amer J Physiol 33, 1996, 733-738
59. Boden, G., Chen, X., Ruiz, J., White, J. V., Rosetti, L.: Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93, 1994, 2438-2446.
60. Roust, L. R., Jensen, M. D.: Postprandial free fatty acid kinetics are abnormal in upper body obesity, Diabetes 42, 1993, 1567-1573
61. Woolett, L. A., Spady, D. K., Dietschy, J. M.: Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate J. Lipid Res. 33, 1992, 77-88.
62. Hegsted, D. M.: Dietary fatty acids, serum cholesterol and coronary heart disease. In: Health Effects of Dietary Fatty Acids. Nelson, G. J (ed). American Oil Chemists' Society. Champaign 1991, 50-68.
63. Warden, C. H., Fisler, J. S.: Identification of genes underlying polygenic obesity in animal models. In: The Genetics of Obesity. C. Bouchard (ed). CRC Press, Boca Raton, FL 1994, 181-197.